Cargando…

Xiaoke Decoction in treatment of type II diabetes: A Meta-analysis

OBJECTIVE: To systematically evaluate the clinical effect of Xiaoke Decoction in the treatment of type 2 diabetes. METHODS: Chinese databases such as CNKI, Wanfang, Weipu Chinese Biomedical Journal Database, and Chinese Medical Biological Literature Database, PubMed, Cochrane Library, Embase, and We...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Baochang, Zhang, Guoqing, Guo, Wenfang, Ren, Cunxia, Li, Minhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476783/
https://www.ncbi.nlm.nih.gov/pubmed/36120131
http://dx.doi.org/10.1016/j.chmed.2021.08.004
_version_ 1784790214549438464
author Zhou, Baochang
Zhang, Guoqing
Guo, Wenfang
Ren, Cunxia
Li, Minhui
author_facet Zhou, Baochang
Zhang, Guoqing
Guo, Wenfang
Ren, Cunxia
Li, Minhui
author_sort Zhou, Baochang
collection PubMed
description OBJECTIVE: To systematically evaluate the clinical effect of Xiaoke Decoction in the treatment of type 2 diabetes. METHODS: Chinese databases such as CNKI, Wanfang, Weipu Chinese Biomedical Journal Database, and Chinese Medical Biological Literature Database, PubMed, Cochrane Library, Embase, and Web of Science were searched for English language literature from their inception until November 2019. A Meta-analysis was performed using RevMan 5.3 and Stata 12.0. RESULTS: Thirty-eight studies were included in this study, with a total of 3757 patients. It was found that adding Xiaoke Decoction could improve total efficiency. The Xiaoke Decoction groups surpassed the western medicine groups regarding improvement in total efficiency (OR = 3.49; 95% CI: 2.78–4.39, P < 0.00001). Adding Xiaoke Decoction could lower the fasting plasma glucose (FPG) level. The Xiaoke Decoction groups surpassed the western medicine groups regarding reduction in FPG levels (MD = −1.14; 95% CI: −1.36 to 0.92, P < 0.00001). Adding Xiaoke Decoction could lower the 2 h postprandial blood glucose (2hPG) level. The Xiaoke Decoction groups surpassed the western medicine groups regarding reduction in 2hPG (MD = −1.40; 95% CI: −1.61 to 1.19, P < 0.00001). Adding Xiaoke Decoction could lower glycated hemoglobin (HbA1c). The Xiaoke Decoction groups surpassed the western medicine groups regarding reduction in HbA1c (MD = −0.77; 95% CI: −0.95 to 0.58, P < 0.00001). It was found that adding Xiaoke Decoction could lower the traditional Chinese medicine (TCM) syndrome score. The TCM syndrome scores among patients in the Xiaoke Decoction group were lower than those among patients in the control group after treatment (MD = −4.90; 95% CI: −7.22 to 2.57, P < 0.0001). At the same time, we conducted a subgroup and sensitivity analysis of age and intervention duration on the heterogeneity of total efficiency, FPG, 2hPG, HbAlc, and TCM syndrome score outcome indicators. For detecting publication bias, an egger test was conducted. CONCLUSION: Compared with western medicine alone, Xiaoke Decoction has more advantages for the treatment of type 2 diabetes with respect to total efficiency, FPG, 2hPG, HbAlc, and TCM syndrome score.
format Online
Article
Text
id pubmed-9476783
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94767832022-09-16 Xiaoke Decoction in treatment of type II diabetes: A Meta-analysis Zhou, Baochang Zhang, Guoqing Guo, Wenfang Ren, Cunxia Li, Minhui Chin Herb Med Original Article OBJECTIVE: To systematically evaluate the clinical effect of Xiaoke Decoction in the treatment of type 2 diabetes. METHODS: Chinese databases such as CNKI, Wanfang, Weipu Chinese Biomedical Journal Database, and Chinese Medical Biological Literature Database, PubMed, Cochrane Library, Embase, and Web of Science were searched for English language literature from their inception until November 2019. A Meta-analysis was performed using RevMan 5.3 and Stata 12.0. RESULTS: Thirty-eight studies were included in this study, with a total of 3757 patients. It was found that adding Xiaoke Decoction could improve total efficiency. The Xiaoke Decoction groups surpassed the western medicine groups regarding improvement in total efficiency (OR = 3.49; 95% CI: 2.78–4.39, P < 0.00001). Adding Xiaoke Decoction could lower the fasting plasma glucose (FPG) level. The Xiaoke Decoction groups surpassed the western medicine groups regarding reduction in FPG levels (MD = −1.14; 95% CI: −1.36 to 0.92, P < 0.00001). Adding Xiaoke Decoction could lower the 2 h postprandial blood glucose (2hPG) level. The Xiaoke Decoction groups surpassed the western medicine groups regarding reduction in 2hPG (MD = −1.40; 95% CI: −1.61 to 1.19, P < 0.00001). Adding Xiaoke Decoction could lower glycated hemoglobin (HbA1c). The Xiaoke Decoction groups surpassed the western medicine groups regarding reduction in HbA1c (MD = −0.77; 95% CI: −0.95 to 0.58, P < 0.00001). It was found that adding Xiaoke Decoction could lower the traditional Chinese medicine (TCM) syndrome score. The TCM syndrome scores among patients in the Xiaoke Decoction group were lower than those among patients in the control group after treatment (MD = −4.90; 95% CI: −7.22 to 2.57, P < 0.0001). At the same time, we conducted a subgroup and sensitivity analysis of age and intervention duration on the heterogeneity of total efficiency, FPG, 2hPG, HbAlc, and TCM syndrome score outcome indicators. For detecting publication bias, an egger test was conducted. CONCLUSION: Compared with western medicine alone, Xiaoke Decoction has more advantages for the treatment of type 2 diabetes with respect to total efficiency, FPG, 2hPG, HbAlc, and TCM syndrome score. Elsevier 2021-08-27 /pmc/articles/PMC9476783/ /pubmed/36120131 http://dx.doi.org/10.1016/j.chmed.2021.08.004 Text en © 2021 Tianjin Press of Chinese Herbal Medicines. Published by ELSEVIER B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Zhou, Baochang
Zhang, Guoqing
Guo, Wenfang
Ren, Cunxia
Li, Minhui
Xiaoke Decoction in treatment of type II diabetes: A Meta-analysis
title Xiaoke Decoction in treatment of type II diabetes: A Meta-analysis
title_full Xiaoke Decoction in treatment of type II diabetes: A Meta-analysis
title_fullStr Xiaoke Decoction in treatment of type II diabetes: A Meta-analysis
title_full_unstemmed Xiaoke Decoction in treatment of type II diabetes: A Meta-analysis
title_short Xiaoke Decoction in treatment of type II diabetes: A Meta-analysis
title_sort xiaoke decoction in treatment of type ii diabetes: a meta-analysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476783/
https://www.ncbi.nlm.nih.gov/pubmed/36120131
http://dx.doi.org/10.1016/j.chmed.2021.08.004
work_keys_str_mv AT zhoubaochang xiaokedecoctionintreatmentoftypeiidiabetesametaanalysis
AT zhangguoqing xiaokedecoctionintreatmentoftypeiidiabetesametaanalysis
AT guowenfang xiaokedecoctionintreatmentoftypeiidiabetesametaanalysis
AT rencunxia xiaokedecoctionintreatmentoftypeiidiabetesametaanalysis
AT liminhui xiaokedecoctionintreatmentoftypeiidiabetesametaanalysis